HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnosis and management of generalized anxiety disorder and panic disorder in adults.

Abstract
Generalized anxiety disorder (GAD) and panic disorder (PD) are among the most common mental disorders in the United States, and they can negatively impact a patient's quality of life and disrupt important activities of daily living. Evidence suggests that the rates of missed diagnoses and misdiagnosis of GAD and PD are high, with symptoms often ascribed to physical causes. Diagnosing GAD and PD requires a broad differential and caution to identify confounding variables and comorbid conditions. Screening and monitoring tools can be used to help make the diagnosis and monitor response to therapy. The GAD-7 and the Severity Measure for Panic Disorder are free diagnostic tools. Successful outcomes may require a combination of treatment modalities tailored to the individual patient. Treatment often includes medications such as selective serotonin reuptake inhibitors and/or psychotherapy, both of which are highly effective. Among psychotherapeutic treatments, cognitive behavior therapy has been studied widely and has an extensive evidence base. Benzodiazepines are effective in reducing anxiety symptoms, but their use is limited by risk of abuse and adverse effect profiles. Physical activity can reduce symptoms of GAD and PD. A number of complementary and alternative treatments are often used; however, evidence is limited for most. Several common botanicals and supplements can potentiate serotonin syndrome when used in combination with antidepressants. Medication should be continued for 12 months before tapering to prevent relapse.
AuthorsAmy B Locke, Nell Kirst, Cameron G Shultz
JournalAmerican family physician (Am Fam Physician) Vol. 91 Issue 9 Pg. 617-24 (May 01 2015) ISSN: 1532-0650 [Electronic] United States
PMID25955736 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Anxiety Agents
  • Antidepressive Agents
  • Serotonin Uptake Inhibitors
Topics
  • Adult
  • Anti-Anxiety Agents (therapeutic use)
  • Antidepressive Agents (therapeutic use)
  • Anxiety Disorders (diagnosis, epidemiology, etiology, therapy)
  • Comorbidity
  • Diagnosis, Differential
  • Dietary Supplements
  • Humans
  • Life Style
  • Panic Disorder (diagnosis, epidemiology, etiology, therapy)
  • Patient Education as Topic
  • Phytotherapy
  • Prevalence
  • Psychiatric Status Rating Scales
  • Psychotherapy
  • Referral and Consultation
  • Relaxation Therapy
  • Selective Serotonin Reuptake Inhibitors (therapeutic use)
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: